Market Cap 1.33B
Revenue (ttm) 313.90M
Net Income (ttm) -20.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6.44%
Debt to Equity Ratio 0.00
Volume 869,200
Avg Vol 966,334
Day's Range N/A - N/A
Shares Out 49.35M
Stochastic %K 69%
Beta 0.82
Analysts Hold
Price Target $25.00

Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers,...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 626 303 7902
Fax: 626 359 8402
Address:
25510 Commercentre Drive, Lake Forest, United States
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Oct. 24 at 12:01 PM
$STAA Ooooo I love shareholder revolts
1 · Reply
StocktwitsNews
StocktwitsNews Oct. 23 at 5:27 PM
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-stock-rises-after-adjournment-of-stockholders-meeting-to-discuss-proposed-merger-with-alcon/cLG4FXDR3rj
0 · Reply
Mergerbrief
Mergerbrief Oct. 23 at 12:21 PM
$STAA / $ALC - Shareholder Vote $STAA MergerBrief.com
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 7:21 PM
Broadwood Partners, L.P., the largest shareholder of STAAR Surgical, announced plans to call a special meeting to remove several board members, intensifying its campaign against STAAR’s proposed $28-per-share sale to Alcon AG. Broadwood said the move follows “overwhelming opposition” to the deal and warned directors not to delay the upcoming shareholder vote or modify the agreement without “meaningful input and alignment with shareholders.” Founder and Chairman Neal C. Bradsher stated that the current board “no longer has shareholders’ confidence” and called for new directors to lead a transparent review of strategic alternatives “free from conflicts and process flaws” seen in the Alcon deal. The announcement comes after growing pressure on STAAR’s board. $STAA $ALC
0 · Reply
scalperD
scalperD Oct. 17 at 2:24 PM
$STAA - Broadwood has to know who the other buyer is and what they would pay for STAA- they are not in the business of losing clients $. I bet on a bump by Alcon
0 · Reply
RUNNINWILD
RUNNINWILD Oct. 16 at 12:21 PM
$STAA getting Jack hammered in pre market let’s see how it goes at open
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 7 at 4:03 PM
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company $STAA https://stocktwits.com/news/equity/markets/staar-surgical-long-term-shareholder-says-proposed-deal-with-alcon-undervalues-company/ch6P0tZR3hj
0 · Reply
Taunus1986
Taunus1986 Oct. 3 at 12:43 PM
$STAA https://www.sec.gov/Archives/edgar/data/718937/000121390025095514/ea0259891-dfan14a_broadwood.htm
0 · Reply
RUNNINWILD
RUNNINWILD Oct. 3 at 1:55 AM
$STAA On October 2, 2025, Broadwood Partners, L.P., collectively with its affiliates, issued an investor presentation titled “The Wrong Time, Wrong Process and Wrong Price,” a copy of which is filed herewith as Exhibit 1. http://archive.fast-edgar.com/20251002/AB29C22CLZ22AJ3L22Z92ZY2P8F4Z222Z27Q/
0 · Reply
StockBraker
StockBraker Sep. 30 at 3:18 PM
$STAA ICYMI Hong Kong-headquartered investment management firm Yunqi Capital on Monday **announced its opposition** to STAAR Surgical Company’s (STAA) proposed sale to Alcon (ALC). Yunqi holds a 5.1% stake in STAAR Surgical Company and has been an investor since 2023. The firm, which claims to be approximately the sixth-largest shareholder of STAAR, stated that it opposes the acquisition of STAAR on the terms announced in August.
1 · Reply
Latest News on STAA
STAAR Surgical Reports Second Quarter 2025 Results

Aug 6, 2025, 4:01 PM EDT - 2 months ago

STAAR Surgical Reports Second Quarter 2025 Results


Top 2 Health Care Stocks You May Want To Dump In Q3

Aug 5, 2025, 9:11 AM EDT - 2 months ago

Top 2 Health Care Stocks You May Want To Dump In Q3

SNN


Alcon Agrees to Acquire STAAR Surgical

Aug 5, 2025, 1:01 AM EDT - 2 months ago

Alcon Agrees to Acquire STAAR Surgical

ALC


BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Oct. 24 at 12:01 PM
$STAA Ooooo I love shareholder revolts
1 · Reply
StocktwitsNews
StocktwitsNews Oct. 23 at 5:27 PM
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-stock-rises-after-adjournment-of-stockholders-meeting-to-discuss-proposed-merger-with-alcon/cLG4FXDR3rj
0 · Reply
Mergerbrief
Mergerbrief Oct. 23 at 12:21 PM
$STAA / $ALC - Shareholder Vote $STAA MergerBrief.com
0 · Reply
topstockalerts
topstockalerts Oct. 22 at 7:21 PM
Broadwood Partners, L.P., the largest shareholder of STAAR Surgical, announced plans to call a special meeting to remove several board members, intensifying its campaign against STAAR’s proposed $28-per-share sale to Alcon AG. Broadwood said the move follows “overwhelming opposition” to the deal and warned directors not to delay the upcoming shareholder vote or modify the agreement without “meaningful input and alignment with shareholders.” Founder and Chairman Neal C. Bradsher stated that the current board “no longer has shareholders’ confidence” and called for new directors to lead a transparent review of strategic alternatives “free from conflicts and process flaws” seen in the Alcon deal. The announcement comes after growing pressure on STAAR’s board. $STAA $ALC
0 · Reply
scalperD
scalperD Oct. 17 at 2:24 PM
$STAA - Broadwood has to know who the other buyer is and what they would pay for STAA- they are not in the business of losing clients $. I bet on a bump by Alcon
0 · Reply
RUNNINWILD
RUNNINWILD Oct. 16 at 12:21 PM
$STAA getting Jack hammered in pre market let’s see how it goes at open
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 7 at 4:03 PM
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company $STAA https://stocktwits.com/news/equity/markets/staar-surgical-long-term-shareholder-says-proposed-deal-with-alcon-undervalues-company/ch6P0tZR3hj
0 · Reply
Taunus1986
Taunus1986 Oct. 3 at 12:43 PM
$STAA https://www.sec.gov/Archives/edgar/data/718937/000121390025095514/ea0259891-dfan14a_broadwood.htm
0 · Reply
RUNNINWILD
RUNNINWILD Oct. 3 at 1:55 AM
$STAA On October 2, 2025, Broadwood Partners, L.P., collectively with its affiliates, issued an investor presentation titled “The Wrong Time, Wrong Process and Wrong Price,” a copy of which is filed herewith as Exhibit 1. http://archive.fast-edgar.com/20251002/AB29C22CLZ22AJ3L22Z92ZY2P8F4Z222Z27Q/
0 · Reply
StockBraker
StockBraker Sep. 30 at 3:18 PM
$STAA ICYMI Hong Kong-headquartered investment management firm Yunqi Capital on Monday **announced its opposition** to STAAR Surgical Company’s (STAA) proposed sale to Alcon (ALC). Yunqi holds a 5.1% stake in STAAR Surgical Company and has been an investor since 2023. The firm, which claims to be approximately the sixth-largest shareholder of STAAR, stated that it opposes the acquisition of STAAR on the terms announced in August.
1 · Reply
RUNNINWILD
RUNNINWILD Sep. 30 at 1:55 PM
$STAA would not be surprised if the deal gets botched and this takes off like a rocket
0 · Reply
RUNNINWILD
RUNNINWILD Sep. 28 at 2:00 PM
$STAA watching this one closely ..the management wants to sell this one out at the lows 🤔 🧐
0 · Reply
imatisse
imatisse Sep. 24 at 2:40 PM
$STAA You can assume that Broadwood is highly attuned — sharp, and ready to move when the moment calls for it
0 · Reply
imatisse
imatisse Sep. 24 at 12:50 PM
$STAA There is simply no way to know how many other parties might have been interested, nor what these alternative potential bidders (and others) might have proposed, if only the Board had bothered to engage properly. The hurried and limited “window shop” period is no substitute for a well-run strategic alternatives process — even though it may provide the Board the fig leaf of fiduciary duty protection under the law.
0 · Reply
imatisse
imatisse Sep. 24 at 12:48 PM
$STAA Broadwood Believes the Transaction Delivers Less Value than Alternatives, Including a Properly Run Strategic Alternatives Process or Improved Execution as a Standalone Business !!!
1 · Reply
imatisse
imatisse Sep. 24 at 12:46 PM
$STAA Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon !!! https://www.businesswire.com/news/home/20250924319207/en/Broadwood-Partners-Files-Definitive-Proxy-Statement-Soliciting-STAAR-Surgical-Stockholders-to-Vote-AGAINST-Proposed-Acquisition-by-Alcon
1 · Reply
StocktwitsNews
StocktwitsNews Sep. 22 at 12:37 PM
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why $STAA $ALC https://stocktwits.com/news/equity/markets/staar-surgical-shareholder-yunqi-capital-opposes-proposed-merger-with-alcon/chDQFDHR32a
0 · Reply
imatisse
imatisse Sep. 8 at 12:57 PM
$STAA Buy-out $40!
0 · Reply
Taunus1986
Taunus1986 Sep. 4 at 7:05 PM
$STAA Just in, BO-Value should be a lot higher ☝🏻 https://m.youtube.com/watch?v=V9g4tnLL2r4&pp=0gcJCRsBo7VqN5tD
0 · Reply
StockBraker
StockBraker Aug. 15 at 1:43 PM
$STAA How is this trading above $28??
1 · Reply
TradeSun
TradeSun Aug. 8 at 4:44 PM
0 · Reply
JarvisFlow
JarvisFlow Aug. 7 at 11:30 AM
Stifel has adjusted their stance on Staar Surgical ( $STAA ), setting the rating to Hold with a target price of 20 → 28.
0 · Reply